Catalyst Brief

← Calendar

Readoutin 76d

Celltrion — CT-P51

Phase 3 primary completion: A Study to Compare Effects and Safety of CT-P51 and Keytruda in Patients With Previously Untreated Metastatic Lung Cancer.

Date
Feb 2027
Type
Readout
Indication
Non Squamous Non Small Cell Lung Cancer

Source ↗Add to calendar

Get told when this date moves

The weekly brief is free. Pro adds reminders 7 days and 1 day before.

More from Celltrion

  1. Mar2027
    Readoutin 104d
    Celltrion — CT-P44(Daratumumab)
    Phase 3 primary completion: A Study to Compare Pharmacokinetics, Efficacy and Safety of Subcutaneous CT-P44 and Darzalex Faspro in Combination With Lenalidomide and Dexamethasone in Patients With Refractory or Relapsed Multiple Myeloma.